Literature DB >> 14744815

EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.

Richard J Davis1, Colin E Murdoch, Mozam Ali, Stuart Purbrick, Rivka Ravid, Gordon S Baxter, Nick Tilford, Robert L G Sheldrick, Kenneth L Clark, Robert A Coleman.   

Abstract

1. Dilatation of the cerebral vasculature is recognised to be involved in the pathophysiology of migraine. Furthermore, elevated levels of prostaglandin E(2) (PGE(2)) occur in the blood, plasma and saliva of migraineurs during an attack, suggestive of a contributory role. In the present study, we have characterised the prostanoid receptors involved in the relaxation and contraction of human middle cerebral arteries in vitro. 2. In the presence of indomethacin (3 microm) and the TP receptor antagonist GR32191 (1 microM), PGE(2) was found to relax phenylephrine precontracted cerebral arterial rings in a concentration-dependent manner (mean pEC(50) 8.0+/-0.1, n=5). 3. Establishment of a rank order of potency using the EP(4)>EP(2) agonist 11-deoxy PGE(1), and the EP(2)>EP(4) agonist PGE(1)-OH (mean pEC(50) of 7.6+/-0.1 (n=6) and 6.4+/-0.1 (n=4), respectively), suggested the presence of functional EP(4) receptors. Furthermore, the selective EP(2) receptor agonist butaprost at concentrations <1 microM failed to relax the tissues. 4. Blockade of EP(4) receptors with the EP(4) receptor antagonists AH23848 and EP(4)A caused significant rightward displacements in PGE(2) concentration-response curves, exhibiting pA(2) and pK(B) values of 5.7+/-0.1, n=3, and 8.4, n=3, respectively. 5. The IP receptor agonists iloprost and cicaprost relaxed phenylephrine precontracted cerebral arterial rings (mean pEC(50) values 8.3+/-0.1 (n=4) and 8.1+/-0.1 (n=9), respectively). In contrast, the DP and FP receptor agonists PGD(2) and PGF(2 alpha) failed to cause appreciable relaxation or contraction at concentrations of up to 30 microm. In the absence of phenylephrine contraction and GR32191, the TP receptor agonist U46619 caused concentration-dependent contraction of cerebral artery (mean pEC(50) 7.4+/-0.3, n=3). 6. These data demonstrate the presence of prostanoid EP(4) receptors mediating PGE(2) vasodilatation of human middle cerebral artery. IP receptors mediating relaxation and TP receptors mediating contraction were also functionally demonstrated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744815      PMCID: PMC1574229          DOI: 10.1038/sj.bjp.0705645

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Brain stem terminations of the trigeminal and upper spinal ganglia innervation of the cerebrovascular system: WGA-HRP transganglionic study.

Authors:  M A Arbab; T Delgado; L Wiklund; N A Svendgaard
Journal:  J Cereb Blood Flow Metab       Date:  1988-02       Impact factor: 6.200

2.  Relevance of prostaglandins in true menstrual migraine.

Authors:  G Nattero; G Allais; C De Lorenzo; C Benedetto; M Zonca; E Melzi; M Massobrio
Journal:  Headache       Date:  1989-04       Impact factor: 5.887

3.  The effect of infused prostacyclin in migraine and cluster headache.

Authors:  R C Peatfield; M J Gawel; F C Rose
Journal:  Headache       Date:  1981-09       Impact factor: 5.887

4.  Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979.

Authors:  P J Gardiner
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

5.  Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial.

Authors:  M J Prior; K M Cooper; L G May; D L Bowen
Journal:  Cephalalgia       Date:  2002-11       Impact factor: 6.292

6.  A 7-day oral treatment of patients with active rheumatoid arthritis using the prostacyclin analog iloprost: cytokine modulation, safety, and clinical effects.

Authors:  Ino K Gao; Peter Scholz; Michael W J Boehme; Cornelia Norden; Ernst-Martin Lemmel
Journal:  Rheumatol Int       Date:  2002-05-03       Impact factor: 2.631

7.  Effect of removal of the endothelium on vasocontraction in canine and rabbit basilar arteries.

Authors:  T Nakagomi; N F Kassell; T Sasaki; R M Lehman; J C Torner; K Hongo; J H Lee
Journal:  J Neurosurg       Date:  1988-05       Impact factor: 5.115

8.  Responses of isolated feline and human cerebral arteries to prostacyclin and some of its metabolites.

Authors:  T Uski; K E Andersson; L Brandt; L Edvinsson; B Ljunggren
Journal:  J Cereb Blood Flow Metab       Date:  1983-06       Impact factor: 6.200

Review 9.  Prostaglandins in alcohol intolerance and hangover.

Authors:  J Parantainen
Journal:  Drug Alcohol Depend       Date:  1983-06       Impact factor: 4.492

10.  GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.

Authors:  P Lumley; B P White; P P Humphrey
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

View more
  44 in total

Review 1.  The physiology of developmental changes in BOLD functional imaging signals.

Authors:  Julia J Harris; Clare Reynell; David Attwell
Journal:  Dev Cogn Neurosci       Date:  2011-04-27       Impact factor: 6.464

Review 2.  Potassium channels and neurovascular coupling.

Authors:  Kathryn M Dunn; Mark T Nelson
Journal:  Circ J       Date:  2010-03-16       Impact factor: 2.993

Review 3.  Mechanisms Mediating Functional Hyperemia in the Brain.

Authors:  Amy R Nippert; Kyle R Biesecker; Eric A Newman
Journal:  Neuroscientist       Date:  2017-04-12       Impact factor: 7.519

4.  A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy.

Authors:  Richard D Kenagy; Seung-Kee Min; Eileen Mulvihill; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2011-04-14       Impact factor: 4.268

Review 5.  Astrocyte regulation of cerebral vascular tone.

Authors:  Jessica A Filosa; Jennifer A Iddings
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-21       Impact factor: 4.733

6.  A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages.

Authors:  Meir Goldsmith; Ala Daka; Nadia F Lamour; Roi Mashiach; Yifat Glucksam; Michael M Meijler; Charles E Chalfant; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2010-10-30       Impact factor: 3.685

Review 7.  Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity.

Authors:  Dejan Milatovic; Thomas J Montine; Michael Aschner
Journal:  Neurotoxicology       Date:  2011-03-03       Impact factor: 4.294

Review 8.  Beyond neurovascular coupling, role of astrocytes in the regulation of vascular tone.

Authors:  J A Filosa; H W Morrison; J A Iddings; W Du; K J Kim
Journal:  Neuroscience       Date:  2015-04-03       Impact factor: 3.590

9.  Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors.

Authors:  S Ayabe; T Murata; T Maruyama; M Hori; H Ozaki
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 10.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.